Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$67.33 - $77.71 $1.16 Million - $1.34 Million
17,181 Added 27.51%
79,639 $6.13 Million
Q1 2024

May 13, 2024

BUY
$57.6 - $68.62 $1.92 Million - $2.29 Million
33,370 Added 114.72%
62,458 $4.28 Million
Q4 2023

Feb 12, 2024

SELL
$48.64 - $57.81 $1.56 Million - $1.85 Million
-32,028 Reduced 52.41%
29,088 $1.68 Million
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $2.47 Million - $2.7 Million
49,304 Added 417.41%
61,116 $3.23 Million
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $145,480 - $159,876
2,926 Added 32.93%
11,812 $638,000
Q1 2023

May 10, 2023

SELL
$45.09 - $50.03 $119,939 - $133,079
-2,660 Reduced 23.04%
8,886 $444,000
Q4 2022

Feb 10, 2023

BUY
$39.56 - $47.22 $36,830 - $43,961
931 Added 8.77%
11,546 $534,000
Q3 2022

Nov 14, 2022

BUY
$36.71 - $109.66 $122,060 - $364,619
3,325 Added 45.61%
10,615 $411,000
Q2 2022

Aug 11, 2022

SELL
$35.24 - $47.1 $422,598 - $564,823
-11,992 Reduced 62.19%
7,290 $272,000
Q1 2022

May 13, 2022

BUY
$40.9 - $45.1 $523,192 - $576,919
12,792 Added 197.1%
19,282 $854,000
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $247,074 - $291,206
6,490 New
6,490 $276,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $141B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Simplify Asset Management Inc. Portfolio

Follow Simplify Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Simplify Asset Management Inc. with notifications on news.